消化威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 消化威廉亚洲博彩公司

2020 JSGE循证临床实践威廉亚洲博彩公司 ：炎症性肠病

2021-04-22 日本胃肠病学会 J Gastroenterol.2021 Apr 22.

炎症性肠病

2021年4月，日本胃肠病学会(JSGE)炎症性肠病临床实践威廉亚洲博彩公司 2020年版英文版发布。本文是对2016年版威廉亚洲博彩公司 的更新主要针对炎症性肠病的诊断和治疗提供循证指导建议。

中文标题：

2020 JSGE循证临床实践威廉亚洲博彩公司 ：炎症性肠病

英文标题：

Evidence-based clinical practice guidelines for inflammatory bowel disease 2020

发布机构：

日本胃肠病学会

发布日期：

2021-04-22

简要介绍：

2021年4月，日本胃肠病学会(JSGE)炎症性肠病临床实践威廉亚洲博彩公司 2020年版英文版发布。本文是对2016年版威廉亚洲博彩公司 的更新主要针对炎症性肠病的诊断和治疗提供循证指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 JSGE循证临床实践威廉亚洲博彩公司 ：炎症性肠病.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ed95a1c002092977, title=2020 JSGE循证临床实践威廉亚洲博彩公司 ：炎症性肠病, enTitle=Evidence-based clinical practice guidelines for inflammatory bowel disease 2020, guiderFrom=J Gastroenterol.2021 Apr 22., authorId=0, author=, summary=2021年4月，日本胃肠病学会(JSGE)炎症性肠病临床实践威廉亚洲博彩公司 2020年版英文版发布。本文是对2016年版威廉亚洲博彩公司 的更新主要针对炎症性肠病的诊断和治疗提供循证指导建议。, cover=https://img.medsci.cn/202158/1620486481875_2020535.jpg, journalId=0, articlesId=null, associationId=1109, associationName=日本胃肠病学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Apr 22 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月，日本胃肠病学会(JSGE)炎症性肠病临床实践威廉亚洲博彩公司 2020年版英文版发布。本文是对2016年版威廉亚洲博彩公司 的更新主要针对炎症性肠病的诊断和治疗提供循证指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1125, tagName=炎症性肠病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1125, guiderKeyword=炎症性肠病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6737, appHits=298, showAppHits=0, pcHits=1107, showPcHits=6439, likes=2, shares=32, comments=13, approvalStatus=1, publishedTime=Sat May 08 23:28:46 CST 2021, publishedTimeString=2021-04-22, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 08 23:08:06 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 07:12:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 JSGE循证临床实践威廉亚洲博彩公司 ：炎症性肠病.pdf)])
2020 JSGE循证临床实践威廉亚洲博彩公司 ：炎症性肠病.pdf
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1230491, encodeId=570a1230491be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:44:05 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075648, encodeId=188610e564898, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:06:49 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073056, encodeId=fff410e3056fb, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da414779546, createdName=812018439, createdTime=Tue Nov 23 02:20:41 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014188, encodeId=da3b10141889c, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIGva1VbaRlGicxU4WwvgCPQ7TqUvNHSESK8A0IWbeg6KTUIKopMYZpBQTz6HhEgfPpFTqyuIOI2nQ/132, createdBy=7a715205116, createdName=小强的姣宝, createdTime=Fri Sep 03 08:22:05 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008657, encodeId=cb7f100865eb7, content=必须好啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:46:47 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2022-07-04 ms3000001902565087

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1230491, encodeId=570a1230491be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:44:05 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075648, encodeId=188610e564898, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:06:49 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073056, encodeId=fff410e3056fb, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da414779546, createdName=812018439, createdTime=Tue Nov 23 02:20:41 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014188, encodeId=da3b10141889c, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIGva1VbaRlGicxU4WwvgCPQ7TqUvNHSESK8A0IWbeg6KTUIKopMYZpBQTz6HhEgfPpFTqyuIOI2nQ/132, createdBy=7a715205116, createdName=小强的姣宝, createdTime=Fri Sep 03 08:22:05 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008657, encodeId=cb7f100865eb7, content=必须好啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:46:47 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-12-01 14号射手

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1230491, encodeId=570a1230491be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:44:05 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075648, encodeId=188610e564898, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:06:49 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073056, encodeId=fff410e3056fb, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da414779546, createdName=812018439, createdTime=Tue Nov 23 02:20:41 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014188, encodeId=da3b10141889c, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIGva1VbaRlGicxU4WwvgCPQ7TqUvNHSESK8A0IWbeg6KTUIKopMYZpBQTz6HhEgfPpFTqyuIOI2nQ/132, createdBy=7a715205116, createdName=小强的姣宝, createdTime=Fri Sep 03 08:22:05 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008657, encodeId=cb7f100865eb7, content=必须好啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:46:47 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-11-23 812018439

    好文章

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1230491, encodeId=570a1230491be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:44:05 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075648, encodeId=188610e564898, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:06:49 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073056, encodeId=fff410e3056fb, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da414779546, createdName=812018439, createdTime=Tue Nov 23 02:20:41 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014188, encodeId=da3b10141889c, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIGva1VbaRlGicxU4WwvgCPQ7TqUvNHSESK8A0IWbeg6KTUIKopMYZpBQTz6HhEgfPpFTqyuIOI2nQ/132, createdBy=7a715205116, createdName=小强的姣宝, createdTime=Fri Sep 03 08:22:05 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008657, encodeId=cb7f100865eb7, content=必须好啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:46:47 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-09-03 小强的姣宝

    好文章！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1230491, encodeId=570a1230491be, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0158135594, createdName=ms3000001902565087, createdTime=Mon Jul 04 15:44:05 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075648, encodeId=188610e564898, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:06:49 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073056, encodeId=fff410e3056fb, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da414779546, createdName=812018439, createdTime=Tue Nov 23 02:20:41 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014188, encodeId=da3b10141889c, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIGva1VbaRlGicxU4WwvgCPQ7TqUvNHSESK8A0IWbeg6KTUIKopMYZpBQTz6HhEgfPpFTqyuIOI2nQ/132, createdBy=7a715205116, createdName=小强的姣宝, createdTime=Fri Sep 03 08:22:05 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008657, encodeId=cb7f100865eb7, content=必须好啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:46:47 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-08-17 DR.Fu SIR

    必须好啊

    0

以上为热门评论，williamhill asia 医学App还有更多内容

相关威廉亚洲博彩公司

2021 ECCO威廉亚洲博彩公司 ：炎症性肠病感染的预防，诊断和管理

欧洲克罗恩病和结肠炎组织(ECCO,European Cron&#039;s and Colitis Organisation) · 2021-03-17

中国炎症性肠病病理诊断专家指导意见

中华医学会消化病学分会炎症性肠病学组 · 2021-01-16

中国炎症性肠病影像检查及报告规范专家指导意见

中国消化科相关专家小组（统称） · 2021-01-16

中国炎症性肠病营养诊疗共识

中华医学会肠外肠内营养学分会(CSPEN,Chinese Society for Parenteral and Enteral Nutrition) · 2021-01-15

2020 ESPGHAN意见书：单基因型炎症性肠病的临床基因组学诊断

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2020-12-16

中国炎症性肠病消化内镜诊疗共识

中国医药教育协会 · 2020-10-30

拓展阅读

2014年加拿大炎症性肠病（IBD）与静脉血栓防治共识意见：加拿大胃肠病学会

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-03-01

2014 ESPGHAN儿童和青少年炎症性肠病诊断的波尔图标准（修订版）

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2014-06-10

2014 CAG立场声明：应用巯嘌呤类药物治疗炎症性肠病

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-07-04

2015 ASGE威廉亚洲博彩公司 ：内镜检查在炎症性肠病中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-03-20

2016 建立我国炎症性肠病诊治中心质量控制指标的共识

中华医学会消化病学分会炎症性肠病学组 · 2016-07-30

2017 IG-IBD临床实践威廉亚洲博彩公司 ：应用糖皮质激素和免疫抑制药物治疗炎症性肠病

意大利炎症性肠病研究组(IG-IBD,Italian Group for the Study of Inflammatory Bowel Disease) · 2017-01-25